BIIB: Biogen Inc. Stock

by  •  • Comments Off on BIIB: Biogen Inc. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 21,571.27
Enterprise Value ($M) 25,492.07
Book Value ($M) 16,716.00
Book Value / Share 114.20
Price / Book 1.29
NCAV ($M) -3,876.50
NCAV / Share -26.48
Price / NCAV -5.56

Profitability (mra)
Return on Invested Capital (ROIC) 0.07
Return on Assets (ROA) 0.06
Return on Equity (ROE) 0.11

Liquidity (mrq)
Quick Ratio 0.90
Current Ratio 1.35

Balance Sheet (mrq) ($M)
Current Assets 7,456.80
Assets 28,049.30
Liabilities 11,333.30
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 9,675.90
Operating Income 2,344.20
Net Income 1,632.20
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 2,875.50
Cash from Investing -799.20
Cash from Financing -683.50

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-12 13G/A Vanguard Group Inc 11.44 0.00
10-16 13G State Street Corp 5.00
08-07 13G/A BlackRock, Inc. 10.10 2.81
2024-02-12 13G/A Primecap Management Co/ca/ 11.22 3.59

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-24 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 534,836 2,630,855 20.33
2025-03-06 238,936 862,495 27.70
2025-03-05 201,604 842,584 23.93
2025-03-04 559,719 2,294,234 24.40
2025-03-03 320,837 1,190,678 26.95

(click for more detail)

Similar Companies
BCRX – BioCryst Pharmaceuticals, Inc. BDTX – Black Diamond Therapeutics, Inc.
BEAM – Beam Therapeutics Inc. BLUE – bluebird bio, Inc.
BMEA – Biomea Fusion, Inc.


Financial data and stock pages provided by
Fintel.io